PDS Biotechnology Corp (NAS:PDSB)
$ 3.51 -0.32 (-8.36%) Market Cap: 128.74 Mil Enterprise Value: 107.77 Mil PE Ratio: 0 PB Ratio: 4.85 GF Score: 35/100

Q1 2021 PDS Biotechnology Corp Earnings Call Transcript

May 13, 2021 / 12:00PM GMT
Release Date Price: $4.48 (+1.82%)
Operator

Hello, and welcome to the PDS Biotechnology First Quarter 2021 Earnings Call and Webcast. (Operator Instructions)

As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Deanne Randolph. Please go ahead.

Deanne Randolph
PDS Biotechnology Corporation - VP of Commericial Development & Head of IR

Good morning, and welcome to PDS Biotechnology's First Quarter 2021 Earnings Conference Call and Audio Webcast. With me today are Dr. Frank Bedu-Addo, Chief Executive Officer; Dr. Lauren B. Wood, Chief Medical Officer; and Dr. Seth Van Voorhees, Chief Financial Officer. Earlier this morning, PDS Biotech issued a press release announcing financial results for the quarter ended March 31, 2021. We encourage everyone to read the press release as well as PDS Biotech's quarterly report on Form 10-Q, which will be filed with the SEC later today. The company's press release is available on PDS Biotech's website at pdsbiotech.com, and the quarterly report will be posted later today. In addition, this conference call is being

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot